{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:23:41Z","timestamp":1791393821397,"version":"4.3.3"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s11894-007-0066-4","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:03:30Z","timestamp":1196957010000},"page":"497-507","source":"Crossref","is-referenced-by-count":89,"title":["Microbial host interactions in IBD: Implications for pathogenesis and therapy"],"prefix":"10.1007","volume":"9","author":[{"given":"R.","family":"Balfour Sartor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Muehlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,6]]},"reference":[{"key":"66_CR1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/510385","volume":"44","author":"P.B. Eckburg","year":"2007","unstructured":"Eckburg PB, Relman DA: The role of microbes in Crohn\u2019s disease. Clin Infect Dis 2007, 44:256\u2013262.","journal-title":"Clin Infect Dis"},{"key":"66_CR2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI30587","volume":"117","author":"W. Strober","year":"2007","unstructured":"Strober W, Fuss I, Mannon P: The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117:514\u2013521.","journal-title":"J Clin Invest"},{"key":"66_CR3","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/MCG.0b013e31802db364","volume":"41","author":"R.B. Sartor","year":"2007","unstructured":"Sartor RB: Bacteria in Crohn\u2019s disease: mechanisms of inflammation and therapeutic implications. J Clin Gastroenterol 2007, 41:S37\u2013S43.","journal-title":"J Clin Gastroenterol"},{"key":"66_CR4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","volume":"3","author":"R.B. Sartor","year":"2006","unstructured":"Sartor RB: Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006, 3:390\u2013407.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"66_CR5","doi-asserted-by":"crossref","unstructured":"Frank DN, St Amand AL, Feldman RA, et al.: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, [In press].","DOI":"10.1073\/pnas.0706625104"},{"key":"66_CR6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"P.B. Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, et al.: Diversity of the human intestinal microbial flora. Science 2005, 308:1635\u20131638.","journal-title":"Science"},{"key":"66_CR7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"R.E. Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022\u20131023.","journal-title":"Nature"},{"key":"66_CR8","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JCM.43.7.3380-3389.2005","volume":"43","author":"A. Swidsinski","year":"2005","unstructured":"Swidsinski A, Weber J, Loening-Baucke V, et al.: Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005, 43:3380\u20133389.","journal-title":"J Clin Microbiol"},{"key":"66_CR9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","volume":"126","author":"W.S. Mow","year":"2004","unstructured":"Mow WS, Vasiliauskas EA, Lin YC, et al.: Association of antibody responses to microbial antigens and complications of small bowel Crohn\u2019s disease. Gastroenterology 2004, 126:414\u2013424.","journal-title":"Gastroenterology"},{"key":"66_CR10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1572-0241.2006.00456.x","volume":"101","author":"M.C. Dubinsky","year":"2006","unstructured":"Dubinsky MC, Lin YC, Dutridge D, et al.: Serum immune responses predict rapid disease progression among children with Crohn\u2019s disease: immune responses predict disease progression. Am J Gastroenterol 2006, 101:360\u2013367.","journal-title":"Am J Gastroenterol"},{"key":"66_CR11","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2004.060228","volume":"54","author":"E. Israeli","year":"2005","unstructured":"Israeli E, Grotto I, Gilburd B, et al.: Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005, 54:1232\u20131236.","journal-title":"Gut"},{"key":"66_CR12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.mib.0000235833.47423.d7","volume":"12","author":"J. Spivak","year":"2006","unstructured":"Spivak J, Landers CJ, Vasiliauskas EA, et al.: Antibodies to I2 predict clinical response to fecal diversion in Crohn\u2019s disease. Inflamm Bowel Dis 2006, 12:1122\u20131130.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1023\/B:DDAS.0000037824.66186.e2","volume":"49","author":"W.S. Mow","year":"2004","unstructured":"Mow WS, Landers CJ, Steinhart AH, et al.: High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn\u2019s disease: a pilot study. Dig Dis Sci 2004, 49:1280\u20131286.","journal-title":"Dig Dis Sci"},{"key":"66_CR14","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2006.02.013","volume":"130","author":"L. Mei","year":"2006","unstructured":"Mei L, Targan SR, Landers CJ, et al.: Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn\u2019s disease. Gastroenterology 2006, 130:1078\u20131085.","journal-title":"Gastroenterology"},{"key":"66_CR15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ibd.20106","volume":"13","author":"K.A. Papadakis","year":"2007","unstructured":"Papadakis KA, Yang H, Ippoliti A, et al.: Anti-flagellin (CBir1) phenotypic and genetic Crohn\u2019s disease associations. Inflamm Bowel Dis 2007, 13:524\u2013530.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1053\/j.gastro.2006.11.013","volume":"132","author":"S.M. Devlin","year":"2007","unstructured":"Devlin SM, Yang H, Ippoliti A, et al.: NOD2 variants and antibody response to microbial antigens in Crohn\u2019s disease patients and their unaffected relatives. Gastroenterology 2007, 132:576\u2013586.","journal-title":"Gastroenterology"},{"key":"66_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1747","volume":"6","author":"W. Strober","year":"2006","unstructured":"Strober W, Murray PJ, Kitani A, Watanabe T: Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006, 6:9\u201320.","journal-title":"Nat Rev Immunol"},{"key":"66_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1954","volume":"39","author":"J. Hampe","year":"2007","unstructured":"Hampe J, Franke A, Rosenstiel P, et al.: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn\u2019s disease in ATG16L1. Nat Genet 2007, 39:207\u2013211.","journal-title":"Nat Genet"},{"key":"66_CR19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ng2032","volume":"39","author":"J.D. Rioux","year":"2007","unstructured":"Rioux JD, Xavier RJ, Taylor KD, et al.: Genome-wide association study identifies new susceptibility loci for Crohn\u2019s disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39:596\u2013604.","journal-title":"Nat Genet"},{"key":"66_CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1155\/2006\/250490","volume":"20","author":"S. Lal","year":"2006","unstructured":"Lal S, Steinhart AH: Antibiotic therapy for Crohn\u2019s disease: a review. Can J Gastroenterol 2006, 20:651\u2013655.","journal-title":"Can J Gastroenterol"},{"key":"66_CR21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1196\/annals.1326.005","volume":"1072","author":"S.K. Bohm","year":"2006","unstructured":"Bohm SK, Kruis W: Probiotics: do they help to control intestinal inflammation? Ann N Y Acad Sci 2006, 1072:339\u2013350.","journal-title":"Ann N Y Acad Sci"},{"key":"66_CR22","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","volume":"126","author":"R.B. Sartor","year":"2004","unstructured":"Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 2004, 126:1620\u20131633.","journal-title":"Gastroenterology"},{"key":"66_CR23","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4049\/jimmunol.178.3.1809","volume":"178","author":"G. Bamias","year":"2007","unstructured":"Bamias G, Okazawa A, Rivera-Nieves J, et al.: Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis. J Immunol 2007, 178:1809\u20131818.","journal-title":"J Immunol"},{"key":"66_CR24","first-page":"G1461","volume":"276","author":"M. Schultz","year":"1999","unstructured":"Schultz M, Tonkonogy SL, Sellon RK, et al.: IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 1999, 276:G1461\u2013G1472.","journal-title":"Am J Physiol"},{"key":"66_CR25","doi-asserted-by":"crossref","unstructured":"Kim SK, Tonkonogy SL, Karrasch T, et al.: Dual association of gnotobiotic IL-10-\/-mice with two nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis 2007, [In press].","DOI":"10.1002\/ibd.20246"},{"key":"66_CR26","first-page":"A512","volume":"128","author":"S.C. Kim","year":"2005","unstructured":"Kim SC, Tonkonogy SL, Albright CA, Sartor RB: Different host genetic backgrounds determine disease phenotypes induced by selective bacterial colonization [abstract]. Gastroenterology 2005, 128:A512.","journal-title":"Gastroenterology"},{"key":"66_CR27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2005.02.009","volume":"128","author":"S.C. Kim","year":"2005","unstructured":"Kim SC, Tonkonogy SL, Albright CA, et al.: Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005, 128:891\u2013906.","journal-title":"Gastroenterology"},{"key":"66_CR28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","volume":"113","author":"M.J. Lodes","year":"2004","unstructured":"Lodes MJ, Cong Y, Elson CO, et al.: Bacterial flagellin is a dominant antigen in Crohn\u2019s disease. J Clin Invest 2004, 113:1296\u20131306.","journal-title":"J Clin Invest"},{"key":"66_CR29","first-page":"44","volume":"21","author":"R.B. Sartor","year":"2005","unstructured":"Sartor RB: Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005, 21:44\u201350.","journal-title":"Curr Opin Gastroenterol"},{"key":"66_CR30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/01.mib.0000228183.70197.dd","volume":"12","author":"M.A. Behr","year":"2006","unstructured":"Behr MA, Schurr E: Mycobacteria in Crohn\u2019s disease: a persistent hypothesis. Inflamm Bowel Dis 2006, 12:1000\u20131004.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/gut.2004.055889","volume":"54","author":"R.B. Sartor","year":"2005","unstructured":"Sartor RB: Does Mycobacterium avium subspecies paratuberculosis cause Crohn\u2019s disease? Gut 2005, 54:896\u2013898.","journal-title":"Gut"},{"key":"66_CR32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/gut.2004.045526","volume":"54","author":"F. Autschbach","year":"2005","unstructured":"Autschbach F, Eisold S, Hinz U, et al.: High prevalence of Mycobacterium avium subsp. paratuberculosis IS900 DNA in gut tissues from individuals with Crohn\u2019s disease. Gut 2005, 54:944\u2013999.","journal-title":"Gut"},{"key":"66_CR33","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.3748\/wjg.v12.i44.7161","volume":"12","author":"L.A. Sechi","year":"2006","unstructured":"Sechi LA, Gazouli M, Sieswerda LE, et al.: Relationship between Crohn\u2019s disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol 2006, 12:7161\u20137164.","journal-title":"World J Gastroenterol"},{"key":"66_CR34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ibd.20114","volume":"13","author":"R.B. Sartor","year":"2007","unstructured":"Sartor RB, Blumberg RS, Braun J, et al.: CCFA microbial-host interactions workshop: highlights and key observations. Inflamm Bowel Dis 2007, 13:600\u2013619.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR35","first-page":"BR130","volume":"12","author":"J. Rumsey","year":"2006","unstructured":"Rumsey J, Valentine JF, Naser SA: Inhibition of phagosome maturation and survival of Mycobacterium avium subspecies paratuberculosis in polymorphonuclear leukocytes from Crohn\u2019s disease patients. Med Sci Monit 2006, 12:BR130\u2013BR139.","journal-title":"Med Sci Monit"},{"key":"66_CR36","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1128\/JCM.43.10.5275-5277.2005","volume":"43","author":"L.A. Sechi","year":"2005","unstructured":"Sechi LA, Gazouli M, Ikonomopoulos J, et al.: Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn\u2019s disease, and Sardinians: the way ahead. J Clin Microbiol 2005, 43:5275\u20135277.","journal-title":"J Clin Microbiol"},{"key":"66_CR37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/JCM.02062-06","volume":"45","author":"C.N. Bernstein","year":"2007","unstructured":"Bernstein CN, Wang MH, Sargent M, et al.: Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease. J Clin Microbiol 2007, 45:968\u2013971.","journal-title":"J Clin Microbiol"},{"key":"66_CR38","doi-asserted-by":"crossref","unstructured":"Baumgart M, Dogan B, Rishniw M, et al.: Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn\u2019s disease involving the ileum. ISME J 2007, [In press].","DOI":"10.1038\/ismej.2007.52"},{"key":"66_CR39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/aje\/kwk067","volume":"165","author":"I. Abubakar","year":"2007","unstructured":"Abubakar I, Myhill DJ, Hart AR, et al.: A case-control study of drinking water and dairy products in Crohn\u2019s disease\u2014further investigation of the possible role of Mycobacterium avium paratuberculosis. Am J Epidemiol 2007, 165:776\u2013783.","journal-title":"Am J Epidemiol"},{"key":"66_CR40","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2007.03.031","volume":"132","author":"W. Selby","year":"2007","unstructured":"Selby W, Pavli P, Crotty B, et al.: Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn\u2019s disease. Gastroenterology 2007, 132:2313\u20132319.","journal-title":"Gastroenterology"},{"key":"66_CR41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1572-0241.2002.05613.x","volume":"97","author":"C. Neut","year":"2002","unstructured":"Neut C, Bulois P, Desreumaux P, et al.: Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn\u2019s disease. Am J Gastroenterol 2002, 97:939\u2013946.","journal-title":"Am J Gastroenterol"},{"key":"66_CR42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","volume":"127","author":"A. Darfeuille-Michaud","year":"2004","unstructured":"Darfeuille-Michaud A, Boudeau J, Bulois P, et al.: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn\u2019s disease. Gastroenterology 2004, 127:412\u2013421.","journal-title":"Gastroenterology"},{"key":"66_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOG.0b013e3280105a38","volume":"23","author":"N. Barnich","year":"2007","unstructured":"Barnich N, Darfeuille-Michaud A: Adherent-invasive Escherichia coli and Crohn\u2019s disease. Curr Opin Gastroenterol 2007, 23:16\u201320.","journal-title":"Curr Opin Gastroenterol"},{"key":"66_CR44","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1172\/JCI30504","volume":"117","author":"N. Barnich","year":"2007","unstructured":"Barnich N, Carvalho FA, Glasser AL, et al.: CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007, 117:1566\u20131574.","journal-title":"J Clin Invest"},{"key":"66_CR45","doi-asserted-by":"crossref","unstructured":"Sasaki M, Sitaraman SV, Babbin BA, et al.: Invasive Escherichia coli are a feature of Crohn\u2019s disease. Lab Invest 2007, [In press].","DOI":"10.1038\/labinvest.3700661"},{"key":"66_CR46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/gut.2006.099796","volume":"56","author":"R. Kotlowski","year":"2007","unstructured":"Kotlowski R, Bernstein CN, Sepehri S, Krause DO: High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007, 56:669\u2013675.","journal-title":"Gut"},{"key":"66_CR47","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1128\/IAI.00067-06","volume":"74","author":"K.W. Simpson","year":"2006","unstructured":"Simpson KW, Dogan B, Rishniw M, et al.: Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 2006, 74:4778\u20134792.","journal-title":"Infect Immun"},{"key":"66_CR48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/gast.2002.30294","volume":"122","author":"A. Swidsinski","year":"2002","unstructured":"Swidsinski A, Ladhoff A, Pernthaler A, et al.: Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122:44\u201354.","journal-title":"Gastroenterology"},{"key":"66_CR49","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1365-2958.2007.05638.x","volume":"63","author":"N. Rolhion","year":"2007","unstructured":"Rolhion N, Carvalho FA, Darfeuille-Michaud A: OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn\u2019s disease-associated Escherichia coli strain LF82. Mol Microbiol 2007, 63:1684\u20131700.","journal-title":"Mol Microbiol"},{"key":"66_CR50","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gut.2005.078824","volume":"55","author":"M.P. Conte","year":"2006","unstructured":"Conte MP, Schippa S, Zamboni I, et al.: Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006, 55:1760\u20131767.","journal-title":"Gut"},{"key":"66_CR51","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/003655202320378220","volume":"37","author":"B. Kleessen","year":"2002","unstructured":"Kleessen B, Kroesen AJ, Buhr HJ, Blaut M: Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002, 37:1034\u20131041.","journal-title":"Scand J Gastroenterol"},{"key":"66_CR52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.MIB.0000159663.62651.4f","volume":"11","author":"M. Mylonaki","year":"2005","unstructured":"Mylonaki M, Rayment NB, Rampton DS, et al.: Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:481\u2013487.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR53","first-page":"A705","volume":"132","author":"M. Martinez-Medina","year":"2007","unstructured":"Martinez-Medina M, Aldeguer X, Acero D, et al.: Escherichia coli in the intestinal mucosa of Crohn\u2019s disease patients: just a commensal bacterium? [abstract]. Gastroenterology 2007, 132:A705.","journal-title":"Gastroenterology"},{"key":"66_CR54","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2004.40103.x","volume":"99","author":"P. Ryan","year":"2004","unstructured":"Ryan P, Kelly RG, Lee G, et al.: Bacterial DNA within granulomas of patients with Crohn\u2019s disease\u2014detection by laser capture microdissection and PCR. Am J Gastroenterol 2004, 99:1539\u20131543.","journal-title":"Am J Gastroenterol"},{"key":"66_CR55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1440-1746.2000.02045.x","volume":"15","author":"H. Matsuda","year":"2000","unstructured":"Matsuda H, Fujiyama Y, Andoh A, et al.: Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol 2000, 15:61\u201368.","journal-title":"J Gastroenterol Hepatol"},{"key":"66_CR56","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","volume":"123","author":"C.J. Landers","year":"2002","unstructured":"Landers CJ, Cohavy O, Misra R, et al.: Selected loss of tolerance evidenced by Crohn\u2019s disease-associated immune responses to auto-and microbial antigens. Gastroenterology 2002, 123:689\u2013699.","journal-title":"Gastroenterology"},{"key":"66_CR57","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gut.44.6.812","volume":"44","author":"R. Dichmann","year":"1999","unstructured":"Dichmann R, May E, Heike M, et al.: T cell specificity and cross reactivity towards Enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans. Gut 1999, 44:812\u2013818.","journal-title":"Gut"},{"key":"66_CR58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-230X-5-28","volume":"5","author":"P.C. Yang","year":"2005","unstructured":"Yang PC, Liu T, Wang BQ, et al.: Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis. BMC Gastroenterol 2005, 5:28.","journal-title":"BMC Gastroenterol"},{"key":"66_CR59","first-page":"A701","volume":"137","author":"K. Rhee","year":"2007","unstructured":"Rhee K, Housseau F, Wu S, et al.: Enterotoxigenic Bacteroides fragilis induced colonic inflammation and epithelial hyperplasia in C57bl\/6 mice [abstract]. Gastroenterology 2007, 137:A701.","journal-title":"Gastroenterology"},{"key":"66_CR60","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1128\/JCM.01004-06","volume":"44","author":"U. Gophna","year":"2006","unstructured":"Gophna U, Sommerfeld K, Gophna S, et al.: Differences between tissue-associated intestinal microfloras of patients with Crohn\u2019s disease and ulcerative colitis. J Clin Microbiol 2006, 44:4136\u20134141.","journal-title":"J Clin Microbiol"},{"key":"66_CR61","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1099\/jmm.0.46498-0","volume":"55","author":"R. Bibiloni","year":"2006","unstructured":"Bibiloni R, Mangold M, Madsen KL, et al.: The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn\u2019s disease and ulcerative colitis patients. J Med Microbiol 2006, 55:1141\u20131149.","journal-title":"J Med Microbiol"},{"key":"66_CR62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2005.073817","volume":"55","author":"C. Manichanh","year":"2006","unstructured":"Manichanh C, Rigottier-Gois L, Bonnaud E, et al.: Reduced diversity of faecal microbiota in Crohn\u2019s disease revealed by a metagenomic approach. Gut 2006, 55:205\u2013211.","journal-title":"Gut"},{"key":"66_CR63","first-page":"55","volume":"53","author":"A. Iwaya","year":"2006","unstructured":"Iwaya A, Iiai T, Okamoto H, et al.: Change in the bacterial flora of pouchitis. Hepatogastroenterology 2006, 53:55\u201359.","journal-title":"Hepatogastroenterology"},{"key":"66_CR64","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/JCM.00312-06","volume":"44","author":"P.D. Scanlan","year":"2006","unstructured":"Scanlan PD, Shanahan F, O\u2019Mahony C, Marchesi JR: Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn\u2019s disease. J Clin Microbiol 2006, 44:3980\u20133988.","journal-title":"J Clin Microbiol"},{"key":"66_CR65","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/gut.2006.109686","volume":"56","author":"H. Sokol","year":"2007","unstructured":"Sokol H, Lepage P, Seksik P, et al.: Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut 2007, 56:152\u2013154.","journal-title":"Gut"},{"key":"66_CR66","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/pr060470d","volume":"6","author":"J.R. Marchesi","year":"2007","unstructured":"Marchesi JR, Holmes E, Khan F, et al.: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007, 6:546\u2013551.","journal-title":"J Proteome Res"},{"key":"66_CR67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1463-1318.2005.00833.x","volume":"7","author":"F.M. Smith","year":"2005","unstructured":"Smith FM, Coffey JC, Kell MR, et al.: A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch. Colorectal Dis 2005, 7:563\u2013570.","journal-title":"Colorectal Dis"},{"key":"66_CR68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/gut.2006.095588","volume":"56","author":"J.R. Korzenik","year":"2007","unstructured":"Korzenik JR: Is Crohn\u2019s disease due to defective immunity? Gut 2007, 56:2\u20135.","journal-title":"Gut"},{"key":"66_CR69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(06)68265-2","volume":"367","author":"D.J. Marks","year":"2006","unstructured":"Marks DJ, Harbord MW, MacAllister R, et al.: Defective acute inflammation in Crohn\u2019s disease: a clinical investigation. Lancet 2006, 367:668\u2013678.","journal-title":"Lancet"},{"key":"66_CR70","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/gast.2003.50153","volume":"124","author":"T. Hisamatsu","year":"2003","unstructured":"Hisamatsu T, Suzuki M, Reinecker HC, et al.: CARD15\/NOD2 functions as an anti-bacterial factor in human intestinal epithelial cells. Gastroenterology 2003, 124:993\u20131000.","journal-title":"Gastroenterology"},{"key":"66_CR71","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0505256102","volume":"102","author":"J. Wehkamp","year":"2005","unstructured":"Wehkamp J, Salzman NH, Porter E, et al.: Reduced Paneth cell alpha-defensins in ileal Crohn\u2019s disease. Proc Natl Acad Sci U S A 2005, 102:18129\u201318134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"66_CR72","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ni1092","volume":"5","author":"T. Watanabe","year":"2004","unstructured":"Watanabe T, Kitani A, Murray PJ, Strober W: NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004, 5:800\u2013808.","journal-title":"Nat Immunol"},{"key":"66_CR73","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/505915","volume":"79","author":"K. Fellermann","year":"2006","unstructured":"Fellermann K, Stange DE, Schaeffeler E, et al.: A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn\u2019s disease of the colon. Am J Hum Genet 2006, 79:439\u2013448.","journal-title":"Am J Hum Genet"},{"key":"66_CR74","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/gut.2006.118646","volume":"56","author":"S. Nuding","year":"2007","unstructured":"Nuding S, Fellermann K, Wehkamp J, Stange EF: Reduced mucosal antimicrobial activity in Crohn\u2019s disease of the colon. Gut 2007, 56:1240\u20131247.","journal-title":"Gut"},{"key":"66_CR75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ng1001-223","volume":"29","author":"J.D. Rioux","year":"2001","unstructured":"Rioux JD, Daly M, Silverberg M, et al.: Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn\u2019s disease. Nat Genet 2001, 29:223\u2013228.","journal-title":"Nat Genet"},{"key":"66_CR76","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/hmg\/ddi494","volume":"15","author":"G.T. Ho","year":"2006","unstructured":"Ho GT, Soranzo N, Nimmo ER, et al.: ABCB1\/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a genewide haplotype tagging approach. Hum Mol Genet 2006, 15:797\u2013805.","journal-title":"Hum Mol Genet"},{"key":"66_CR77","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.161.10.5733","volume":"161","author":"C.M. Panwala","year":"1998","unstructured":"Panwala CM, Jones JC, Viney JL: A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, Mdr1a, spontaneously develop colitis. J Immunol 1998, 161:5733\u20135744.","journal-title":"J Immunol"},{"key":"66_CR78","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20050407","volume":"203","author":"T.S. Olson","year":"2006","unstructured":"Olson TS, Reuter BK, Scott KG, et al.: The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med 2006, 203:541\u2013552.","journal-title":"J Exp Med"},{"key":"66_CR79","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ibd.20174","volume":"13","author":"T. Clavel","year":"2007","unstructured":"Clavel T, Haller D: Bacteria-and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 2007, 13:1153\u20131164.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR80","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.0105-2896.2005.00250.x","volume":"204","author":"J.L. Coombes","year":"2005","unstructured":"Coombes JL, Robinson NJ, Maloy KJ, et al.: Regulatory T cells and intestinal homeostasis. Immunol Rev 2005, 204:184\u2013194.","journal-title":"Immunol Rev"},{"key":"66_CR81","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/gut.2004.053116","volume":"54","author":"K. Schreiter","year":"2005","unstructured":"Schreiter K, Hausmann M, Spoettl T, et al.: Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn\u2019s disease. Gut 2005, 54:935\u2013943.","journal-title":"Gut"},{"key":"66_CR82","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1995.tb03836.x","volume":"102","author":"R. Duchmann","year":"1995","unstructured":"Duchmann R, Kaiser I, Hermann E, et al.: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995, 102:448\u2013455.","journal-title":"Clin Exp Immunol"},{"key":"66_CR83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.MIB.0000200343.61707.52","volume":"12","author":"T.A. Kraus","year":"2006","unstructured":"Kraus TA, Cheifetz A, Toy L, et al.: Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:82\u201388.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR84","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2982.2006.00762.x","volume":"18","author":"D. Haller","year":"2006","unstructured":"Haller D: Intestinal epithelial cell signaling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neurogastroenterol Motil 2006, 18:184\u2013199.","journal-title":"Neurogastroenterol Motil"},{"key":"66_CR85","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/B978-012491543-5\/50039-5","volume-title":"Mucosal Immunology","author":"R.B. Sartor","year":"2005","unstructured":"Sartor RB, Hoentjen F: Proinflammatory cytokines and signaling pathways in intestinal innate immune cells. In Mucosal Immunology. Edited by Mestecky J, Lamm ME, Strober W, et al. Boston: Elsevier Academic Press; 2005:681\u2013701."},{"key":"66_CR86","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI119522","volume":"100","author":"M.F. Kagnoff","year":"1997","unstructured":"Kagnoff MF, Eckmann L: Epithelial cells as sensors for microbial infection. J Clin Invest 1997, 100:6\u201310.","journal-title":"J Clin Invest"},{"key":"66_CR87","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.1104911","volume":"307","author":"K.S. Kobayashi","year":"2005","unstructured":"Kobayashi KS, Chamaillard M, Ogura Y, et al.: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731\u2013734.","journal-title":"Science"},{"key":"66_CR88","doi-asserted-by":"crossref","first-page":"G685","DOI":"10.1152\/ajpgi.00404.2005","volume":"290","author":"R. Sharma","year":"2006","unstructured":"Sharma R, Tesfay S, Tomson FL, et al.: Balance of bacterial pro-and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli (EPEC) on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2006, 290:G685\u2013G694.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"66_CR89","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S. Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al.: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229\u2013241.","journal-title":"Cell"},{"key":"66_CR90","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrg1607","volume":"6","author":"S. Schreiber","year":"2005","unstructured":"Schreiber S, Rosenstiel P, Albrecht M, et al.: Genetics of Crohn\u2019s disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005, 6:376\u2013388.","journal-title":"Nat Rev Genet"},{"key":"66_CR91","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.4049\/jimmunol.174.5.2990","volume":"174","author":"P.A. Ruiz","year":"2005","unstructured":"Ruiz PA, Shkoda A, Kim SC, et al.: IL-10 gene-deficient mice lack TGF beta\/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 2005, 174:2990\u20132999.","journal-title":"J Immunol"},{"key":"66_CR92","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature05698","volume":"446","author":"A. Nenci","year":"2007","unstructured":"Nenci A, Becker C, Wullaert A, et al.: Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557\u2013561.","journal-title":"Nature"},{"key":"66_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.MIB.0000195389.11645.ab","volume":"12","author":"M. Pierik","year":"2006","unstructured":"Pierik M, Joossens S, Van Steen K, et al.: Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006, 12:1\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR94","first-page":"183","volume":"10","author":"T. Griga","year":"2005","unstructured":"Griga T, Wilkens C, Schmiegel W, et al.: Association between the promoter polymorphism T\/C at position-159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. Eur J Med Res 2005, 10:183\u2013186.","journal-title":"Eur J Med Res"},{"key":"66_CR95","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bbrc.2005.09.170","volume":"337","author":"A.M. Lamhonwah","year":"2005","unstructured":"Lamhonwah AM, Ackerley C, Onizuka R, et al.: Epitope shared by functional variant of organic cation\/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn\u2019s disease at 5q31. Biochem Biophys Res Commun 2005, 337:1165\u20131175.","journal-title":"Biochem Biophys Res Commun"},{"key":"66_CR96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2006.02.003","volume":"26","author":"A. Rahbar","year":"2006","unstructured":"Rahbar A, Bostrom L, Soderberg-Naucler C: Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn\u2019s disease. J Autoimmun 2006, 26:155\u2013164.","journal-title":"J Autoimmun"},{"key":"66_CR97","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10067-006-0391-2","volume":"26","author":"A. Ebringer","year":"2007","unstructured":"Ebringer A, Rashid T, Tiwana H, Wilson C: A possible link between Crohn\u2019s disease and ankylosing spondylitis via Klebsiella infections. Clin Rheumatol 2007, 26:289\u2013297.","journal-title":"Clin Rheumatol"},{"key":"66_CR98","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2006.04.021","volume":"131","author":"D. Polymeros","year":"2006","unstructured":"Polymeros D, Bogdanos DP, Day R, et al.: Does cross-reactivity between Mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn\u2019s disease? Gastroenterology 2006, 131:85\u201396.","journal-title":"Gastroenterology"},{"key":"66_CR99","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","volume":"5","author":"J.F. Rodemann","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, et al.: Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:339\u2013344.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"66_CR100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","volume":"5","author":"M. Issa","year":"2007","unstructured":"Issa M, Vijayapal A, Graham MB, et al.: Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:345\u2013351.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"66_CR101","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s10620-006-9172-7","volume":"51","author":"B. Shen","year":"2006","unstructured":"Shen B, Goldblum JR, Hull TL, et al.: Clostridium difficile-associated pouchitis. Dig Dis Sci 2006, 51:2361\u20132364.","journal-title":"Dig Dis Sci"},{"key":"66_CR102","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1080\/00365520500408584","volume":"41","author":"T. Kojima","year":"2006","unstructured":"Kojima T, Watanabe T, Hata K, et al.: Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol 2006, 41:706\u2013711.","journal-title":"Scand J Gastroenterol"},{"key":"66_CR103","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1572-0241.2006.00989.x","volume":"102","author":"K. Matsuoka","year":"2007","unstructured":"Matsuoka K, Iwao Y, Mori T, et al.: Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007, 102:331\u2013337.","journal-title":"Am J Gastroenterol"},{"key":"66_CR104","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.clinthera.2006.12.012","volume":"28","author":"R. Rahimi","year":"2006","unstructured":"Rahimi R, Nikfar S, Rezaie A, Abdollahi M: A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn\u2019s disease. Clin Ther 2006, 28:1983\u20131988.","journal-title":"Clin Ther"},{"key":"66_CR105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.MIB.0000225330.38119.c7","volume":"12","author":"M. Perencevich","year":"2006","unstructured":"Perencevich M, Burakoff R: Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:651\u2013664.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR106","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11894-006-0039-z","volume":"8","author":"J.B. Ewaschuk","year":"2006","unstructured":"Ewaschuk JB, Tejpar QZ, Soo I, et al.: The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep 2006, 8:486\u2013498.","journal-title":"Curr Gastroenterol Rep"},{"key":"66_CR107","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3748\/wjg.v12.i21.3306","volume":"12","author":"P. Gionchetti","year":"2006","unstructured":"Gionchetti P, Rizzello F, Lammers KM, et al.: Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 2006, 12:3306\u20133313.","journal-title":"World J Gastroenterol"},{"key":"66_CR108","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2005.01.010","volume":"128","author":"P. Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Van Assche G, Vermeire S, et al.: Ornidazole for prophylaxis of postoperative Crohn\u2019s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005, 128:856\u2013861.","journal-title":"Gastroenterology"},{"key":"66_CR109","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1185\/030079905X53252","volume":"21","author":"I. Shafran","year":"2005","unstructured":"Shafran I, Johnson L: An open-label evaluation of rifaximin in the treatment of active Crohn\u2019s disease. Curr Med Res Opin 2005, 21:1165\u20131169.","journal-title":"Curr Med Res Opin"},{"key":"66_CR110","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2036.2006.02879.x","volume":"23","author":"C. Prantera","year":"2006","unstructured":"Prantera C, Lochs H, Campieri M, et al.: Antibiotic treatment of Crohn\u2019s disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006, 23:1117\u20131125.","journal-title":"Aliment Pharmacol Ther"},{"key":"66_CR111","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1080\/00365520510023648","volume":"40","author":"T. Ohkusa","year":"2005","unstructured":"Ohkusa T, Nomura T, Terai T, et al.: Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up. Scand J Gastroenterol 2005, 40:1334\u20131342.","journal-title":"Scand J Gastroenterol"},{"key":"66_CR112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00004836-200603000-00019","volume":"40","author":"K.P. Rioux","year":"2006","unstructured":"Rioux KP, Fedorak RN: Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 2006, 40:260\u2013263.","journal-title":"J Clin Gastroenterol"},{"key":"66_CR113","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0029665107005563","volume":"66","author":"C. Hedin","year":"2007","unstructured":"Hedin C, Whelan K, Lindsay JO: Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007, 66:307\u2013315.","journal-title":"Proc Nutr Soc"},{"key":"66_CR114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004836-200603000-00022","volume":"40","author":"M.H. Floch","year":"2006","unstructured":"Floch MH, Madsen KK, Jenkins DJ, et al.: Recommendations for probiotic use. J Clin Gastroenterol 2006, 40:275\u2013278.","journal-title":"J Clin Gastroenterol"},{"key":"66_CR115","first-page":"23","volume":"57","author":"T. Mach","year":"2006","unstructured":"Mach T: Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 2006, 57:23\u201333.","journal-title":"J Physiol Pharmacol"},{"key":"66_CR116","doi-asserted-by":"crossref","first-page":"819S","DOI":"10.1093\/jn\/137.3.819S","volume":"137","author":"B. Sheil","year":"2007","unstructured":"Sheil B, Shanahan F, O\u2019Mahony L: Probiotic effects on inflammatory bowel disease. J Nutr 2007, 137:819S\u2013824S.","journal-title":"J Nutr"},{"key":"66_CR117","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","volume":"100","author":"R. Bibiloni","year":"2005","unstructured":"Bibiloni R, Fedorak R, Tannock GW, et al.: VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005, 100:1539\u20131546.","journal-title":"Am J Gastroenterol"},{"key":"66_CR118","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1365-2036.2006.02927.x","volume":"23","author":"M.A. Zocco","year":"2006","unstructured":"Zocco MA, dal Verme LZ, Cremonini F, et al.: Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 2006, 23:1567\u20131574.","journal-title":"Aliment Pharmacol Ther"},{"key":"66_CR119","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1368-5031.2006.00833.x","volume":"60","author":"A.P. Bai","year":"2006","unstructured":"Bai AP, Ouyang Q, Xiao XR, Li SF: Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int J Clin Pract 2006, 60:284\u2013288.","journal-title":"Int J Clin Pract"},{"key":"66_CR120","doi-asserted-by":"crossref","unstructured":"Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F: Probiotics for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2006, (4):CD004826.","DOI":"10.1002\/14651858.CD004826.pub2"},{"key":"66_CR121","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.MIB.0000175905.00212.2c","volume":"11","author":"A. Bousvaros","year":"2005","unstructured":"Bousvaros A, Guandalini S, Baldassano RN, et al.: A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn\u2019s disease. Inflamm Bowel Dis 2005, 11:833\u2013839.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR122","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ibd.20063","volume":"13","author":"A. Gossum Van","year":"2007","unstructured":"Van Gossum A, Dewit O, Louis E, et al.: Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn\u2019s disease after ileo-caecal resection. Inflamm Bowel Dis 2007, 13:135\u2013142.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR123","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","volume":"55","author":"P. Marteau","year":"2006","unstructured":"Marteau P, Lemann M, Seksik P, et al.: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn\u2019s disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006, 55:842\u2013847.","journal-title":"Gut"},{"key":"66_CR124","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1189\/jlb.0405188","volume":"79","author":"M. Carol","year":"2006","unstructured":"Carol M, Borruel N, Antolin M, et al.: Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn\u2019s disease. J Leukoc Biol 2006, 79:917\u2013922.","journal-title":"J Leukoc Biol"},{"key":"66_CR125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000094041","volume":"73","author":"S. Cukovic-Cavka","year":"2006","unstructured":"Cukovic-Cavka S, Likic R, Francetic I, et al.: Lactobacillus acidophilus as a cause of liver abscess in a NOD2\/CARD15-positive patient with Crohn\u2019s disease. Digestion 2006, 73:107\u2013110.","journal-title":"Digestion"},{"key":"66_CR126","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","volume":"4","author":"H. Braat","year":"2006","unstructured":"Braat H, Rottiers P, Hommes DW, et al.: A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease. Clin Gastroenterol Hepatol 2006, 4:754\u2013759.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"66_CR127","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.mib.0000235101.09231.9e","volume":"12","author":"W. Han","year":"2006","unstructured":"Han W, Mercenier A, Ait-Belgnaoui A, et al.: Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 2006, 12:1044\u20131052.","journal-title":"Inflamm Bowel Dis"},{"key":"66_CR128","doi-asserted-by":"crossref","first-page":"G729","DOI":"10.1152\/ajpgi.00132.2007","volume":"293","author":"I.M. Carroll","year":"2007","unstructured":"Carroll IM, Andrus JM, Bruno-Barcena JM, et al.: Anti-inflammatory properties of Lactobacillus gasseri expressing managese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G729\u2013G739.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"66_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2006.10.006","volume":"115","author":"M.S. Geier","year":"2007","unstructured":"Geier MS, Butler RN, Howarth GS: Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 2007, 115:1\u201311.","journal-title":"Int J Food Microbiol"},{"key":"66_CR130","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2036.2007.03288.x","volume":"25","author":"F. Casellas","year":"2007","unstructured":"Casellas F, Borruel N, Torrejon A, et al.: Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 2007, 25:1061\u20131067.","journal-title":"Aliment Pharmacol Ther"},{"key":"66_CR131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.53.1.91","volume":"53","author":"E. Furrie","year":"2004","unstructured":"Furrie E, Macfarlane S, Cummings JH, Macfarlane GT: Systemic antibodies towards mucosal bacterial in ulcerative colitis and Crohn\u2019s disease differentially activate the innate immune response. Gut 2004, 53:91\u201398.","journal-title":"Gut"},{"key":"66_CR132","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1080\/00365520510023585","volume":"40","author":"S. Lewis","year":"2005","unstructured":"Lewis S, Brazier J, Beard D, et al.: Effects of metronidazole and oligofructose on faecal concentrations of sulphate-reducing bacteria and their activity in human volunteers. Scand J Gastroenterol 2005, 40:1296\u20131303.","journal-title":"Scand J Gastroenterol"},{"key":"66_CR133","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nut.2005.04.013","volume":"22","author":"A. Suzuki","year":"2006","unstructured":"Suzuki A, Mitsuyama K, Koga H, et al.: Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition 2006, 22:76\u201381.","journal-title":"Nutrition"},{"key":"66_CR134","first-page":"799","volume":"232","author":"E.K. Tai","year":"2007","unstructured":"Tai EK, Wu WK, Wong HP, et al.: A new role for cathelicidin in ulcerative colitis in mice. Exp Biol Med (Maywood) 2007, 232:799\u2013808.","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-007-0066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-007-0066-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-007-0066-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T04:48:18Z","timestamp":1684126098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-007-0066-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":134,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s11894-007-0066-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}